Hi RLGPhD,
It wasn’t factual (your post). The CLARITY 2.0 and REMAP-CAP International COVID-19 trials are covered $.
FSGS next step in Ph3 & correct we are waiting on news for that to hear how that will be covered in a larger & lengthier trial. It was always the plan for DKD to be out-licenced.
Why my comment, & it wasn’t intended to be rude, your posts are usually more in-depth in explanation, but that one wasn’t. That’s all.
Ann: Half Year Report and Update, page-77
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.005(1.49%) |
Mkt cap ! $181.3M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.121M | 3.386M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 907553 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 195382 | 3 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.0¢ |
Change
-0.005 ( 1.49 %) |
||||
| Open | High | Low | Volume | ||
| 33.5¢ | 34.0¢ | 32.5¢ | 1712129 | ||
| Last updated 15.54pm 10/05/2024 ? | |||||
| DXB (ASX) Chart |